Blockade of the CD40–CD40L and CD80/CD86–CD28 costimulatory pathways represents a strategy to inhibit the immune response against Ad vectors designed for gene therapy applications. Since most previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback